Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $144,500 - $337,900
-2,000 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$93.0 - $171.7 $186,000 - $343,400
2,000 New
2,000 $321,000
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $164,760 - $263,280
-2,000 Closed
0 $0
Q4 2019

Jan 14, 2020

SELL
$76.53 - $135.58 $76,530 - $135,580
-1,000 Reduced 33.33%
2,000 $258,000
Q3 2019

Oct 31, 2019

SELL
$72.81 - $156.91 $3.05 Million - $6.57 Million
-41,845 Reduced 93.31%
3,000 $226,000
Q2 2019

Jul 31, 2019

SELL
$112.21 - $151.95 $4.8 Million - $6.5 Million
-42,810 Reduced 48.84%
44,845 $6.81 Million
Q1 2019

Apr 30, 2019

BUY
$106.67 - $151.68 $3.54 Million - $5.03 Million
33,150 Added 60.82%
87,655 $10.4 Million
Q4 2018

Feb 08, 2019

SELL
$97.32 - $148.76 $1 Million - $1.53 Million
-10,280 Reduced 15.87%
54,505 $5.95 Million
Q3 2018

Nov 13, 2018

BUY
$115.31 - $161.51 $3.9 Million - $5.46 Million
33,810 Added 109.15%
64,785 $10.5 Million
Q2 2018

Aug 13, 2018

BUY
$71.74 - $153.69 $64,565 - $138,321
900 Added 2.99%
30,975 $4.09 Million
Q1 2018

May 14, 2018

BUY
$54.02 - $82.27 $27,010 - $41,135
500 Added 1.69%
30,075 $2.23 Million
Q4 2017

Feb 13, 2018

BUY
$47.64 - $56.75 $1.41 Million - $1.68 Million
29,575
29,575 $1.65 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $6.45B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.